MYMETHAZINE FORTIS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mymethazine Fortis, and when can generic versions of Mymethazine Fortis launch?
Mymethazine Fortis is a drug marketed by Usl Pharma and is included in one NDA.
The generic ingredient in MYMETHAZINE FORTIS is promethazine hydrochloride. There are twelve drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mymethazine Fortis
A generic version of MYMETHAZINE FORTIS was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.
Summary for MYMETHAZINE FORTIS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Patent Applications: | 2,430 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYMETHAZINE FORTIS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYMETHAZINE FORTIS
US Patents and Regulatory Information for MYMETHAZINE FORTIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Usl Pharma | MYMETHAZINE FORTIS | promethazine hydrochloride | SYRUP;ORAL | 087996-001 | Jan 18, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |